[
    {
        "molecule_name": "antibody or antibody fragment",
        "protein_target_name": "CD269",
        "binding_metric": "affinity",
        "value": "20",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In another aspect the antibody or antibody fragment of the invention binds CD269 with high affinity, for example when measured by surface plasmon resonance, such as Biacore, the antibody binds to human CD269 with an affinity of 20 nM or less or an affinity of 15 nM or less or an affinity of 5 nM or less or an affinity of 1000 pM or less or an affinity of 500 pM or less or an affinity of 100 pM or less, or 800 pM or less or for example about 54 pM.\nIn a further embodiment the antibody binds to human CD269 when measured by surface plasmon resonance, such as Biacore, of between about 1 pM and about 500 pM or between about 10 pM and about 200 pM, or between about 20 pM and about 100 pM.\nIn one embodiment of the present invention the antibody binds CD269 with an affinity of around 50 pM."
    },
    {
        "molecule_name": "antibody or antibody fragment",
        "protein_target_name": "CD269",
        "binding_metric": "affinity",
        "value": "15",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In another aspect the antibody or antibody fragment of the invention binds CD269 with high affinity, for example when measured by surface plasmon resonance, such as Biacore, the antibody binds to human CD269 with an affinity of 20 nM or less or an affinity of 15 nM or less or an affinity of 5 nM or less or an affinity of 1000 pM or less or an affinity of 500 pM or less or an affinity of 100 pM or less, or 800 pM or less or for example about 54 pM.\nIn a further embodiment the antibody binds to human CD269 when measured by surface plasmon resonance, such as Biacore, of between about 1 pM and about 500 pM or between about 10 pM and about 200 pM, or between about 20 pM and about 100 pM.\nIn one embodiment of the present invention the antibody binds CD269 with an affinity of around 50 pM."
    },
    {
        "molecule_name": "antibody or antibody fragment",
        "protein_target_name": "CD269",
        "binding_metric": "affinity",
        "value": "5",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In another aspect the antibody or antibody fragment of the invention binds CD269 with high affinity, for example when measured by surface plasmon resonance, such as Biacore, the antibody binds to human CD269 with an affinity of 20 nM or less or an affinity of 15 nM or less or an affinity of 5 nM or less or an affinity of 1000 pM or less or an affinity of 500 pM or less or an affinity of 100 pM or less, or 800 pM or less or for example about 54 pM.\nIn a further embodiment the antibody binds to human CD269 when measured by surface plasmon resonance, such as Biacore, of between about 1 pM and about 500 pM or between about 10 pM and about 200 pM, or between about 20 pM and about 100 pM.\nIn one embodiment of the present invention the antibody binds CD269 with an affinity of around 50 pM."
    },
    {
        "molecule_name": "antibody or antibody fragment",
        "protein_target_name": "CD269",
        "binding_metric": "affinity",
        "value": "1000",
        "unit": "pM",
        "is_logarithmic": false,
        "raw_mentions": "In another aspect the antibody or antibody fragment of the invention binds CD269 with high affinity, for example when measured by surface plasmon resonance, such as Biacore, the antibody binds to human CD269 with an affinity of 20 nM or less or an affinity of 15 nM or less or an affinity of 5 nM or less or an affinity of 1000 pM or less or an affinity of 500 pM or less or an affinity of 100 pM or less, or 800 pM or less or for example about 54 pM.\nIn a further embodiment the antibody binds to human CD269 when measured by surface plasmon resonance, such as Biacore, of between about 1 pM and about 500 pM or between about 10 pM and about 200 pM, or between about 20 pM and about 100 pM.\nIn one embodiment of the present invention the antibody binds CD269 with an affinity of around 50 pM."
    },
    {
        "molecule_name": "antibody or antibody fragment",
        "protein_target_name": "CD269",
        "binding_metric": "affinity",
        "value": "500",
        "unit": "pM",
        "is_logarithmic": false,
        "raw_mentions": "In another aspect the antibody or antibody fragment of the invention binds CD269 with high affinity, for example when measured by surface plasmon resonance, such as Biacore, the antibody binds to human CD269 with an affinity of 20 nM or less or an affinity of 15 nM or less or an affinity of 5 nM or less or an affinity of 1000 pM or less or an affinity of 500 pM or less or an affinity of 100 pM or less, or 800 pM or less or for example about 54 pM.\nIn a further embodiment the antibody binds to human CD269 when measured by surface plasmon resonance, such as Biacore, of between about 1 pM and about 500 pM or between about 10 pM and about 200 pM, or between about 20 pM and about 100 pM.\nIn one embodiment of the present invention the antibody binds CD269 with an affinity of around 50 pM."
    },
    {
        "molecule_name": "antibody or antibody fragment",
        "protein_target_name": "CD269",
        "binding_metric": "affinity",
        "value": "100",
        "unit": "pM",
        "is_logarithmic": false,
        "raw_mentions": "In another aspect the antibody or antibody fragment of the invention binds CD269 with high affinity, for example when measured by surface plasmon resonance, such as Biacore, the antibody binds to human CD269 with an affinity of 20 nM or less or an affinity of 15 nM or less or an affinity of 5 nM or less or an affinity of 1000 pM or less or an affinity of 500 pM or less or an affinity of 100 pM or less, or 800 pM or less or for example about 54 pM.\nIn a further embodiment the antibody binds to human CD269 when measured by surface plasmon resonance, such as Biacore, of between about 1 pM and about 500 pM or between about 10 pM and about 200 pM, or between about 20 pM and about 100 pM.\nIn one embodiment of the present invention the antibody binds CD269 with an affinity of around 50 pM."
    },
    {
        "molecule_name": "antibody or antibody fragment",
        "protein_target_name": "CD269",
        "binding_metric": "affinity",
        "value": "800",
        "unit": "pM",
        "is_logarithmic": false,
        "raw_mentions": "In another aspect the antibody or antibody fragment of the invention binds CD269 with high affinity, for example when measured by surface plasmon resonance, such as Biacore, the antibody binds to human CD269 with an affinity of 20 nM or less or an affinity of 15 nM or less or an affinity of 5 nM or less or an affinity of 1000 pM or less or an affinity of 500 pM or less or an affinity of 100 pM or less, or 800 pM or less or for example about 54 pM.\nIn a further embodiment the antibody binds to human CD269 when measured by surface plasmon resonance, such as Biacore, of between about 1 pM and about 500 pM or between about 10 pM and about 200 pM, or between about 20 pM and about 100 pM.\nIn one embodiment of the present invention the antibody binds CD269 with an affinity of around 50 pM."
    },
    {
        "molecule_name": "antibody or antibody fragment",
        "protein_target_name": "CD269",
        "binding_metric": "affinity",
        "value": "54",
        "unit": "pM",
        "is_logarithmic": false,
        "raw_mentions": "In another aspect the antibody or antibody fragment of the invention binds CD269 with high affinity, for example when measured by surface plasmon resonance, such as Biacore, the antibody binds to human CD269 with an affinity of 20 nM or less or an affinity of 15 nM or less or an affinity of 5 nM or less or an affinity of 1000 pM or less or an affinity of 500 pM or less or an affinity of 100 pM or less, or 800 pM or less or for example about 54 pM.\nIn a further embodiment the antibody binds to human CD269 when measured by surface plasmon resonance, such as Biacore, of between about 1 pM and about 500 pM or between about 10 pM and about 200 pM, or between about 20 pM and about 100 pM.\nIn one embodiment of the present invention the antibody binds CD269 with an affinity of around 50 pM."
    },
    {
        "molecule_name": "antibody or antibody fragment",
        "protein_target_name": "CD269",
        "binding_metric": "affinity",
        "value": "1",
        "unit": "pM",
        "is_logarithmic": false,
        "raw_mentions": "In another aspect the antibody or antibody fragment of the invention binds CD269 with high affinity, for example when measured by surface plasmon resonance, such as Biacore, the antibody binds to human CD269 with an affinity of 20 nM or less or an affinity of 15 nM or less or an affinity of 5 nM or less or an affinity of 1000 pM or less or an affinity of 500 pM or less or an affinity of 100 pM or less, or 800 pM or less or for example about 54 pM.\nIn a further embodiment the antibody binds to human CD269 when measured by surface plasmon resonance, such as Biacore, of between about 1 pM and about 500 pM or between about 10 pM and about 200 pM, or between about 20 pM and about 100 pM.\nIn one embodiment of the present invention the antibody binds CD269 with an affinity of around 50 pM."
    },
    {
        "molecule_name": "antibody or antibody fragment",
        "protein_target_name": "CD269",
        "binding_metric": "affinity",
        "value": "500",
        "unit": "pM",
        "is_logarithmic": false,
        "raw_mentions": "In another aspect the antibody or antibody fragment of the invention binds CD269 with high affinity, for example when measured by surface plasmon resonance, such as Biacore, the antibody binds to human CD269 with an affinity of 20 nM or less or an affinity of 15 nM or less or an affinity of 5 nM or less or an affinity of 1000 pM or less or an affinity of 500 pM or less or an affinity of 100 pM or less, or 800 pM or less or for example about 54 pM.\nIn a further embodiment the antibody binds to human CD269 when measured by surface plasmon resonance, such as Biacore, of between about 1 pM and about 500 pM or between about 10 pM and about 200 pM, or between about 20 pM and about 100 pM.\nIn one embodiment of the present invention the antibody binds CD269 with an affinity of around 50 pM."
    },
    {
        "molecule_name": "antibody or antibody fragment",
        "protein_target_name": "CD269",
        "binding_metric": "affinity",
        "value": "10",
        "unit": "pM",
        "is_logarithmic": false,
        "raw_mentions": "In another aspect the antibody or antibody fragment of the invention binds CD269 with high affinity, for example when measured by surface plasmon resonance, such as Biacore, the antibody binds to human CD269 with an affinity of 20 nM or less or an affinity of 15 nM or less or an affinity of 5 nM or less or an affinity of 1000 pM or less or an affinity of 500 pM or less or an affinity of 100 pM or less, or 800 pM or less or for example about 54 pM.\nIn a further embodiment the antibody binds to human CD269 when measured by surface plasmon resonance, such as Biacore, of between about 1 pM and about 500 pM or between about 10 pM and about 200 pM, or between about 20 pM and about 100 pM.\nIn one embodiment of the present invention the antibody binds CD269 with an affinity of around 50 pM."
    },
    {
        "molecule_name": "antibody or antibody fragment",
        "protein_target_name": "CD269",
        "binding_metric": "affinity",
        "value": "200",
        "unit": "pM",
        "is_logarithmic": false,
        "raw_mentions": "In another aspect the antibody or antibody fragment of the invention binds CD269 with high affinity, for example when measured by surface plasmon resonance, such as Biacore, the antibody binds to human CD269 with an affinity of 20 nM or less or an affinity of 15 nM or less or an affinity of 5 nM or less or an affinity of 1000 pM or less or an affinity of 500 pM or less or an affinity of 100 pM or less, or 800 pM or less or for example about 54 pM.\nIn a further embodiment the antibody binds to human CD269 when measured by surface plasmon resonance, such as Biacore, of between about 1 pM and about 500 pM or between about 10 pM and about 200 pM, or between about 20 pM and about 100 pM.\nIn one embodiment of the present invention the antibody binds CD269 with an affinity of around 50 pM."
    },
    {
        "molecule_name": "antibody or antibody fragment",
        "protein_target_name": "CD269",
        "binding_metric": "affinity",
        "value": "20",
        "unit": "pM",
        "is_logarithmic": false,
        "raw_mentions": "In another aspect the antibody or antibody fragment of the invention binds CD269 with high affinity, for example when measured by surface plasmon resonance, such as Biacore, the antibody binds to human CD269 with an affinity of 20 nM or less or an affinity of 15 nM or less or an affinity of 5 nM or less or an affinity of 1000 pM or less or an affinity of 500 pM or less or an affinity of 100 pM or less, or 800 pM or less or for example about 54 pM.\nIn a further embodiment the antibody binds to human CD269 when measured by surface plasmon resonance, such as Biacore, of between about 1 pM and about 500 pM or between about 10 pM and about 200 pM, or between about 20 pM and about 100 pM.\nIn one embodiment of the present invention the antibody binds CD269 with an affinity of around 50 pM."
    },
    {
        "molecule_name": "antibody or antibody fragment",
        "protein_target_name": "CD269",
        "binding_metric": "affinity",
        "value": "100",
        "unit": "pM",
        "is_logarithmic": false,
        "raw_mentions": "In another aspect the antibody or antibody fragment of the invention binds CD269 with high affinity, for example when measured by surface plasmon resonance, such as Biacore, the antibody binds to human CD269 with an affinity of 20 nM or less or an affinity of 15 nM or less or an affinity of 5 nM or less or an affinity of 1000 pM or less or an affinity of 500 pM or less or an affinity of 100 pM or less, or 800 pM or less or for example about 54 pM.\nIn a further embodiment the antibody binds to human CD269 when measured by surface plasmon resonance, such as Biacore, of between about 1 pM and about 500 pM or between about 10 pM and about 200 pM, or between about 20 pM and about 100 pM.\nIn one embodiment of the present invention the antibody binds CD269 with an affinity of around 50 pM."
    },
    {
        "molecule_name": "antibody or antibody fragment",
        "protein_target_name": "CD269",
        "binding_metric": "affinity",
        "value": "50",
        "unit": "pM",
        "is_logarithmic": false,
        "raw_mentions": "In another aspect the antibody or antibody fragment of the invention binds CD269 with high affinity, for example when measured by surface plasmon resonance, such as Biacore, the antibody binds to human CD269 with an affinity of 20 nM or less or an affinity of 15 nM or less or an affinity of 5 nM or less or an affinity of 1000 pM or less or an affinity of 500 pM or less or an affinity of 100 pM or less, or 800 pM or less or for example about 54 pM.\nIn a further embodiment the antibody binds to human CD269 when measured by surface plasmon resonance, such as Biacore, of between about 1 pM and about 500 pM or between about 10 pM and about 200 pM, or between about 20 pM and about 100 pM.\nIn one embodiment of the present invention the antibody binds CD269 with an affinity of around 50 pM."
    }
]